Most Recent

image: Transparency Now

Transparency Now

By | May 1, 2016

Science is messy. So lay it out, warts and all.

1 Comment

image: Stubbornly Persistent

Stubbornly Persistent

By | February 1, 2015

Microorganisms continually challenge our assumptions of what life can achieve.

1 Comment

image: A Chill Issue

A Chill Issue

By | February 1, 2013

The very cold, the merely chilled, and the colorful

0 Comments

image: In the Long Run

In the Long Run

By | December 1, 2012

Can emulating our early human ancestors make us healthier?

1 Comment

image: Long and Rocky Roads

Long and Rocky Roads

By | November 1, 2012

From basic research to beneficial therapies

0 Comments

image: Survival of the Fittest (to print)

Survival of the Fittest (to print)

By | August 1, 2012

Science publishing is locked in an evolutionary arms race as it edges further into the digital age.

5 Comments

image: Avant-Garde Science

Avant-Garde Science

By | June 1, 2012

Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.

0 Comments

. . . And Many Happy Returns

By | October 1, 2011

To the great scientific leaps witnessed during our first 25 years, and the game changers yet to come.

0 Comments

image: A Shot in the Arm

A Shot in the Arm

By | June 1, 2011

Decades of vaccine research have expanded our understanding of the immune system and are yielding novel disease-fighting tactics.

0 Comments

image: To Err is Human

To Err is Human

By | February 1, 2011

This is your brain on emotions.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech